Mizuho Securities USA LLC cut its holdings in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Free Report) by 38.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 550,000 shares of the company's stock after selling 347,220 shares during the quarter. Mizuho Securities USA LLC owned approximately 8.98% of Aimei Health Technology worth $6,022,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently modified their holdings of the business. Harraden Circle Investments LLC bought a new stake in Aimei Health Technology during the 4th quarter valued at approximately $1,117,000. Berkley W R Corp bought a new stake in Aimei Health Technology during the 4th quarter valued at approximately $4,750,000. Quarry LP bought a new stake in Aimei Health Technology during the 4th quarter valued at approximately $1,605,000. Finally, Centiva Capital LP boosted its position in Aimei Health Technology by 1.4% during the 4th quarter. Centiva Capital LP now owns 232,693 shares of the company's stock valued at $2,460,000 after acquiring an additional 3,100 shares in the last quarter. 45.58% of the stock is owned by institutional investors.
Aimei Health Technology Stock Performance
Aimei Health Technology stock remained flat at $11.17 during trading hours on Thursday. The company's stock had a trading volume of 200 shares, compared to its average volume of 1,659. The business's 50 day moving average price is $11.16 and its 200-day moving average price is $11.04. Aimei Health Technology Co., Ltd. has a fifty-two week low of $10.24 and a fifty-two week high of $11.30.
Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last released its earnings results on Wednesday, August 13th. The company reported $0.07 earnings per share (EPS) for the quarter.
Aimei Health Technology Company Profile
(
Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Featured Stories

Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.